Related Experiment Videos

Schistosoma mansoni: unisexual infections sensitized mice for granuloma formation around intravenously injected eggs

A W Cheever1, F A Lewis, T A Wynn

  • 1Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425, USA.

Parasitology Research
|January 1, 1997
PubMed

Insights

Mice infected with only male or female Schistosoma mansoni showed stronger immune responses to S. mansoni eggs. This suggests cross-reactivity between worm and egg antigens is key in schistosomiasis mansoni.

Area of Science:

  • Immunology
  • Parasitology
  • Pathology

Background:

  • Schistosoma mansoni infection causes significant morbidity.
  • The immune response to S. mansoni eggs is central to pathogenesis.
  • Unisexual infections are less common but can provide insights into immune responses.

Purpose of the Study:

  • To investigate the impact of unisexual Schistosoma mansoni infection on host immune responses to S. mansoni eggs.
  • To compare granuloma formation and eosinophil infiltration in unisexually and bisexually infected mice.

Main Methods:

  • Mice were infected with either male or female S. mansoni for 9 weeks.
  • Intravenous injection of S. mansoni eggs was used to elicit egg-specific immune responses.
  • Lung granuloma size and tissue eosinophilia were quantified.

Main Results:

  • Unisexual S. mansoni infection accelerated and augmented host reactions to intravenously injected S. mansoni eggs.
  • Granuloma size in the lungs of unisexually infected mice was comparable to bisexually infected mice.
  • Tissue eosinophilia within granulomas was similarly augmented in both unisexually and bisexually infected mice compared to naive controls.

Conclusions:

  • Cross-reactivity between S. mansoni worm and egg antigens influences host immune responses.
  • These findings are relevant to understanding acute toxemic schistosomiasis mansoni.
  • The study suggests potential considerations for developing S. mansoni vaccines based on antigen cross-reactivity.

Related Concept Videos